The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases
about
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challengesRegulation of synaptic nlg-1/neuroligin abundance by the skn-1/Nrf stress response pathway protects against oxidative stressKinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1Releasing Nrf2 to promote neurite outgrowthMultiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivoAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseThe cysteine proteomeThe status of Nrf2-based therapeutics: current perspectives and future prospectsOral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.Chronic Oxidative Stress, Mitochondrial Dysfunction, Nrf2 Activation and Inflammation in the Hippocampus Accompany Heightened Systemic Inflammation and Oxidative Stress in an Animal Model of Gulf War IllnessTranscription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation.Challenging oneself intermittently to improve health.Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's diseaseNRF2 promotes neuronal survival in neurodegeneration and acute nerve damage.Long-term Autophagy and Nrf2 Signaling in the Hippocampi of Developing Mice after Carbon Ion Exposure.Isolation of a Hypomorphic skn-1 Allele That Does Not Require a Balancer for Maintenance.Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.Attenuation of β-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2.NFE2L2 variations reduce antioxidant response in patients with Parkinson disease.In vitro and in vivo characterization of a tunable dual-reactivity probe of the Nrf2-ARE pathwayMitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons.Resveratrol restores sirtuin 1 (SIRT1) activity and pyruvate dehydrogenase kinase 1 (PDK1) expression after hemorrhagic injury in a rat model.Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.Spongionella secondary metabolites protect mitochondrial function in cortical neurons against oxidative stress.Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.Do glial cells play an anti-oxidative role in Huntington's disease?Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke.How can we target oxidative stress in the treatment of neurodegenerative diseases?The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?Fine-tuning PERK signaling for neuroprotection.Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.Schisandra chinensis Stem Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity via Activation of the Nrf2 Pathway and Inhibition of the MAPKs and NF-κB Pathways.MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress.Activation of Nrf2-driven antioxidant enzymes by cardamonin confers neuroprotection of PC12 cells against oxidative damage.Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
P2860
Q26747783-FC90572E-AD6E-4B7E-9036-17566F986114Q27317190-0D3D0133-6F1F-4F01-B6E5-02B025E9194CQ27681060-21874BB7-4856-4727-89F4-DDC27E48CDC2Q28385265-C5955ADA-1C85-4415-9820-6E35094F145BQ28386141-04D00123-C313-41AC-BECE-ABAEC6092C51Q28389419-3AD9DBD5-840A-40EE-B2D3-07283BB76E5DQ28394732-D2AAD269-3DD9-42F6-8A1D-E536DDB65C26Q28395817-7B40AC69-EC16-4101-84DC-CA6B307EB6B7Q28818264-405C027C-9EEE-4A50-BC49-60CDBBB6149BQ30847085-794AD84F-49C7-44BB-A650-7CA1EC61A269Q33614523-47945A93-5BBE-49C1-BE3E-F08BC252C41AQ33794702-CB3539C4-3794-4CF5-B75F-94AD281D08F9Q34075866-FF12A82D-CEC3-42DD-9C39-176D5E28B98FQ34710056-30D9AD63-B55A-4241-A041-77AD9EE3C079Q35148188-53FE482F-113A-43C0-9041-2ED6C5EB5299Q35408649-DCE31F07-EC5E-4AE2-98D4-A737D6A6B702Q36392730-EBBBDEA6-EA42-41D5-83F7-A5A087199D72Q36648689-44068993-E85B-45FE-98B0-8CA8FFAB3FBBQ36901132-BEE70953-EF9D-43F1-9B1C-58EF99D416D5Q36995865-B47A90D4-B840-4D3A-B3C0-BB7265FA8F01Q36998083-04FF36D9-16D4-45A0-92B3-D82BB7021C6BQ37120398-D561D130-8B43-45DC-92D2-829389A99112Q37489884-D190445D-24FC-40D5-9455-9BAECE6753FAQ37549574-3BDD436D-5E19-4146-B346-8D69DC1755C5Q37599146-6409C007-5E97-4109-B546-C84F1F7D60D0Q37621110-494B35E0-F8C0-4FC5-BEA4-48BA94D6C36CQ38124678-7082E9FA-7D14-4986-A683-BF8F70BDFAC4Q38137114-08E1A313-70E6-4342-9505-5E863EA0F788Q38222578-F445ED95-C951-459C-A782-E0A30DF56A8DQ38723314-E5621DD3-B7B5-4BD4-A762-CD3436FD731AQ38867900-E47ECDA5-4651-4361-8F39-69AAC53EE510Q38889475-0F0B9CF2-CF06-4F53-BB72-EDCDD4A971D5Q39181656-0B11B08C-396E-4C53-9C1E-1D115137AC89Q39340496-723D52BB-2022-4140-86AC-4C81EA9EEB47Q39393398-952DA1F6-9432-4E2B-9DD7-C1887699C16FQ42252979-60C6F968-AA7D-4447-8CBA-95B8F3752CD5Q42369993-74F26C84-A817-411F-8619-9BA8A2BAAD42Q45233235-DA4F65D5-7393-46F7-8241-BEDFFA66FF87Q46407584-2787CDAE-5B72-4EF7-8A10-E122A81640E7Q46544501-184A0250-B577-43F1-A9F2-0415042098CB
P2860
The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@ast
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@en
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@nl
type
label
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@ast
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@en
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@nl
prefLabel
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@ast
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@en
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@nl
P2860
P3181
P1476
The Nrf2-ARE pathway: a valuab ...... of neurodegenerative diseases
@en
P2093
P2860
P304
P3181
P356
10.2174/157488912803252023
P407
P577
2012-12-01T00:00:00Z